Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Carotil is a complex veterinary preparation primarily used for the treatment of uterine diseases in cows, including chronic endometritis, and for post-cesarean section, assisted parturition, or surgical removal of placenta. It exhibits a broad spectrum of antimicrobial activity, aids in restoring uterine contractile function, and promotes the regeneration of the endometrium. The drug's composition includes tylosin tartrate, carbachol, and beta-carotene. Tylosin tartrate acts as a bacteriostatic agent by inhibiting protein synthesis in various gram-positive and some gram-negative microorganisms. Beta-carotene functions as an antioxidant, inhibiting free radical reactions, protecting cellular biomembranes, and activating metabolism to promote endometrial regeneration and prevent placenta retention. Carbachol increases the tonus and enhances the contraction of uterine muscles.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Carotil.